|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2011-4-4
|
|
pubmed:abstractText |
In Australia, post-marketing surveillance for intussusception following vaccination commenced with funding of RotaTeq(®) and Rotarix(®) vaccines under the National Immunization Program (NIP) in July 2007.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1873-2518
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
5
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3061-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21316503-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:21316503-Australia,
pubmed-meshheading:21316503-Humans,
pubmed-meshheading:21316503-Immunization Programs,
pubmed-meshheading:21316503-Infant,
pubmed-meshheading:21316503-Intussusception,
pubmed-meshheading:21316503-Product Surveillance, Postmarketing,
pubmed-meshheading:21316503-Risk Assessment,
pubmed-meshheading:21316503-Rotavirus Vaccines,
pubmed-meshheading:21316503-Vaccines, Attenuated
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
|
|
pubmed:affiliation |
SAEFVIC in Child and Adolescent Immunisation, Murdoch Children's Research Institute, Parkville, Victoria 3052, Australia. jim.buttery@rch.org.au
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
